EVALUATION OF EFFICACY OF BUSERELIN-DEPO IN PATIENTS WITH LOCALLY ADVANCED AND METHASTATIC PROSTATE CANCER
Our surveillance was performed for 358 here patients with locally advanced and disseminated prostate gland cancer who were treated by analogues of LHRH.Patients in group 1 (n = 222) received treatment with a LHRH analogue, and patients in group 2 (n = 136) received treatment with 75 mg Buserelin-depo 3.Experience has shown that the use of the Buser